The global market for Autologous Stem Cell & Non-stem Cell Therapies was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Autologous stem cell and non-stem cell therapies involve using a patient’s own cells to treat various medical conditions, offering personalized treatment options that minimize the risk of immune rejection and other complications.

North American market for Autologous Stem Cell & Non-stem Cell Therapies is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Autologous Stem Cell & Non-stem Cell Therapies is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Autologous Stem Cell & Non-stem Cell Therapies in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Autologous Stem Cell & Non-stem Cell Therapies include Anterogen Co., Ltd., APAC Biotech, Bristol-Myers Squibb Company, CARsgen Therapeutics Holdings Limited, Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.), Gilead Sciences, Inc., Green Cross Holdings Co., Ltd. (GC Cell), Healiva SA, ImmunoACT, Iaso Biotherapeutics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Autologous Stem Cell & Non-stem Cell Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autologous Stem Cell & Non-stem Cell Therapies.

The Autologous Stem Cell & Non-stem Cell Therapies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Autologous Stem Cell & Non-stem Cell Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Autologous Stem Cell & Non-stem Cell Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Autologous Stem Cell & Non-stem Cell Therapies Market Report

Report Metric	Details
Report Name	Autologous Stem Cell & Non-stem Cell Therapies Market
Segment by Type	CAR-T Tumor Infiltrating Lymphocyte
Segment by Application	Hospital Surgery Center Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Anterogen Co., Ltd., APAC Biotech, Bristol-Myers Squibb Company, CARsgen Therapeutics Holdings Limited, Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.), Gilead Sciences, Inc., Green Cross Holdings Co., Ltd. (GC Cell), Healiva SA, ImmunoACT, Iaso Biotherapeutics, Johnson & Johnson, Lovance Biotherapeutics, Inc., Novartis AG, Pharmicell Co., Ltd., Regrow Biosciences Pvt Ltd., Tegoscience, Vericel Corporation, W (Cayman) Therapeutics Co. Ltd.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Autologous Stem Cell & Non-stem Cell Therapies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Autologous Stem Cell & Non-stem Cell Therapies Market report?

Ans: The main players in the Autologous Stem Cell & Non-stem Cell Therapies Market are Anterogen Co., Ltd., APAC Biotech, Bristol-Myers Squibb Company, CARsgen Therapeutics Holdings Limited, Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.), Gilead Sciences, Inc., Green Cross Holdings Co., Ltd. (GC Cell), Healiva SA, ImmunoACT, Iaso Biotherapeutics, Johnson & Johnson, Lovance Biotherapeutics, Inc., Novartis AG, Pharmicell Co., Ltd., Regrow Biosciences Pvt Ltd., Tegoscience, Vericel Corporation, W (Cayman) Therapeutics Co. Ltd.

What are the Application segmentation covered in the Autologous Stem Cell & Non-stem Cell Therapies Market report?

Ans: The Applications covered in the Autologous Stem Cell & Non-stem Cell Therapies Market report are Hospital, Surgery Center, Other

What are the Type segmentation covered in the Autologous Stem Cell & Non-stem Cell Therapies Market report?

Ans: The Types covered in the Autologous Stem Cell & Non-stem Cell Therapies Market report are CAR-T, Tumor Infiltrating Lymphocyte

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Autologous Stem Cell & Non-stem Cell Therapies Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 CAR-T

1.2.3 Tumor Infiltrating Lymphocyte

1.3 Market by Application

1.3.1 Global Autologous Stem Cell & Non-stem Cell Therapies Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Surgery Center

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Autologous Stem Cell & Non-stem Cell Therapies Market Perspective (2020-2031)

2.2 Global Autologous Stem Cell & Non-stem Cell Therapies Growth Trends by Region

2.2.1 Global Autologous Stem Cell & Non-stem Cell Therapies Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Autologous Stem Cell & Non-stem Cell Therapies Historic Market Size by Region (2020-2025)

2.2.3 Autologous Stem Cell & Non-stem Cell Therapies Forecasted Market Size by Region (2026-2031)

2.3 Autologous Stem Cell & Non-stem Cell Therapies Market Dynamics

2.3.1 Autologous Stem Cell & Non-stem Cell Therapies Industry Trends

2.3.2 Autologous Stem Cell & Non-stem Cell Therapies Market Drivers

2.3.3 Autologous Stem Cell & Non-stem Cell Therapies Market Challenges

2.3.4 Autologous Stem Cell & Non-stem Cell Therapies Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Autologous Stem Cell & Non-stem Cell Therapies Players by Revenue

3.1.1 Global Top Autologous Stem Cell & Non-stem Cell Therapies Players by Revenue (2020-2025)

3.1.2 Global Autologous Stem Cell & Non-stem Cell Therapies Revenue Market Share by Players (2020-2025)

3.2 Global Autologous Stem Cell & Non-stem Cell Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Autologous Stem Cell & Non-stem Cell Therapies Revenue

3.4 Global Autologous Stem Cell & Non-stem Cell Therapies Market Concentration Ratio

3.4.1 Global Autologous Stem Cell & Non-stem Cell Therapies Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Autologous Stem Cell & Non-stem Cell Therapies Revenue in 2024

3.5 Global Key Players of Autologous Stem Cell & Non-stem Cell Therapies Head office and Area Served

3.6 Global Key Players of Autologous Stem Cell & Non-stem Cell Therapies, Product and Application

3.7 Global Key Players of Autologous Stem Cell & Non-stem Cell Therapies, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Autologous Stem Cell & Non-stem Cell Therapies Breakdown Data by Type

4.1 Global Autologous Stem Cell & Non-stem Cell Therapies Historic Market Size by Type (2020-2025)

4.2 Global Autologous Stem Cell & Non-stem Cell Therapies Forecasted Market Size by Type (2026-2031)

5 Autologous Stem Cell & Non-stem Cell Therapies Breakdown Data by Application

5.1 Global Autologous Stem Cell & Non-stem Cell Therapies Historic Market Size by Application (2020-2025)

5.2 Global Autologous Stem Cell & Non-stem Cell Therapies Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Autologous Stem Cell & Non-stem Cell Therapies Market Size (2020-2031)

6.2 North America Autologous Stem Cell & Non-stem Cell Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Autologous Stem Cell & Non-stem Cell Therapies Market Size by Country (2020-2025)

6.4 North America Autologous Stem Cell & Non-stem Cell Therapies Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Autologous Stem Cell & Non-stem Cell Therapies Market Size (2020-2031)

7.2 Europe Autologous Stem Cell & Non-stem Cell Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Autologous Stem Cell & Non-stem Cell Therapies Market Size by Country (2020-2025)

7.4 Europe Autologous Stem Cell & Non-stem Cell Therapies Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Market Size (2020-2031)

8.2 Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Market Size by Region (2020-2025)

8.4 Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Autologous Stem Cell & Non-stem Cell Therapies Market Size (2020-2031)

9.2 Latin America Autologous Stem Cell & Non-stem Cell Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Autologous Stem Cell & Non-stem Cell Therapies Market Size by Country (2020-2025)

9.4 Latin America Autologous Stem Cell & Non-stem Cell Therapies Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Market Size (2020-2031)

10.2 Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Market Size by Country (2020-2025)

10.4 Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Anterogen Co., Ltd.

11.1.1 Anterogen Co., Ltd. Company Details

11.1.2 Anterogen Co., Ltd. Business Overview

11.1.3 Anterogen Co., Ltd. Autologous Stem Cell & Non-stem Cell Therapies Introduction

11.1.4 Anterogen Co., Ltd. Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

11.1.5 Anterogen Co., Ltd. Recent Development

11.2 APAC Biotech

11.2.1 APAC Biotech Company Details

11.2.2 APAC Biotech Business Overview

11.2.3 APAC Biotech Autologous Stem Cell & Non-stem Cell Therapies Introduction

11.2.4 APAC Biotech Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

11.2.5 APAC Biotech Recent Development

11.3 Bristol-Myers Squibb Company

11.3.1 Bristol-Myers Squibb Company Company Details

11.3.2 Bristol-Myers Squibb Company Business Overview

11.3.3 Bristol-Myers Squibb Company Autologous Stem Cell & Non-stem Cell Therapies Introduction

11.3.4 Bristol-Myers Squibb Company Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

11.3.5 Bristol-Myers Squibb Company Recent Development

11.4 CARsgen Therapeutics Holdings Limited

11.4.1 CARsgen Therapeutics Holdings Limited Company Details

11.4.2 CARsgen Therapeutics Holdings Limited Business Overview

11.4.3 CARsgen Therapeutics Holdings Limited Autologous Stem Cell & Non-stem Cell Therapies Introduction

11.4.4 CARsgen Therapeutics Holdings Limited Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

11.4.5 CARsgen Therapeutics Holdings Limited Recent Development

11.5 Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.)

11.5.1 Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.) Company Details

11.5.2 Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.) Business Overview

11.5.3 Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.) Autologous Stem Cell & Non-stem Cell Therapies Introduction

11.5.4 Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.) Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

11.5.5 Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.) Recent Development

11.6 Gilead Sciences, Inc.

11.6.1 Gilead Sciences, Inc. Company Details

11.6.2 Gilead Sciences, Inc. Business Overview

11.6.3 Gilead Sciences, Inc. Autologous Stem Cell & Non-stem Cell Therapies Introduction

11.6.4 Gilead Sciences, Inc. Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

11.6.5 Gilead Sciences, Inc. Recent Development

11.7 Green Cross Holdings Co., Ltd. (GC Cell)

11.7.1 Green Cross Holdings Co., Ltd. (GC Cell) Company Details

11.7.2 Green Cross Holdings Co., Ltd. (GC Cell) Business Overview

11.7.3 Green Cross Holdings Co., Ltd. (GC Cell) Autologous Stem Cell & Non-stem Cell Therapies Introduction

11.7.4 Green Cross Holdings Co., Ltd. (GC Cell) Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

11.7.5 Green Cross Holdings Co., Ltd. (GC Cell) Recent Development

11.8 Healiva SA

11.8.1 Healiva SA Company Details

11.8.2 Healiva SA Business Overview

11.8.3 Healiva SA Autologous Stem Cell & Non-stem Cell Therapies Introduction

11.8.4 Healiva SA Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

11.8.5 Healiva SA Recent Development

11.9 ImmunoACT

11.9.1 ImmunoACT Company Details

11.9.2 ImmunoACT Business Overview

11.9.3 ImmunoACT Autologous Stem Cell & Non-stem Cell Therapies Introduction

11.9.4 ImmunoACT Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

11.9.5 ImmunoACT Recent Development

11.10 Iaso Biotherapeutics

11.10.1 Iaso Biotherapeutics Company Details

11.10.2 Iaso Biotherapeutics Business Overview

11.10.3 Iaso Biotherapeutics Autologous Stem Cell & Non-stem Cell Therapies Introduction

11.10.4 Iaso Biotherapeutics Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

11.10.5 Iaso Biotherapeutics Recent Development

11.11 Johnson & Johnson

11.11.1 Johnson & Johnson Company Details

11.11.2 Johnson & Johnson Business Overview

11.11.3 Johnson & Johnson Autologous Stem Cell & Non-stem Cell Therapies Introduction

11.11.4 Johnson & Johnson Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

11.11.5 Johnson & Johnson Recent Development

11.12 Lovance Biotherapeutics, Inc.

11.12.1 Lovance Biotherapeutics, Inc. Company Details

11.12.2 Lovance Biotherapeutics, Inc. Business Overview

11.12.3 Lovance Biotherapeutics, Inc. Autologous Stem Cell & Non-stem Cell Therapies Introduction

11.12.4 Lovance Biotherapeutics, Inc. Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

11.12.5 Lovance Biotherapeutics, Inc. Recent Development

11.13 Novartis AG

11.13.1 Novartis AG Company Details

11.13.2 Novartis AG Business Overview

11.13.3 Novartis AG Autologous Stem Cell & Non-stem Cell Therapies Introduction

11.13.4 Novartis AG Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

11.13.5 Novartis AG Recent Development

11.14 Pharmicell Co., Ltd.

11.14.1 Pharmicell Co., Ltd. Company Details

11.14.2 Pharmicell Co., Ltd. Business Overview

11.14.3 Pharmicell Co., Ltd. Autologous Stem Cell & Non-stem Cell Therapies Introduction

11.14.4 Pharmicell Co., Ltd. Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

11.14.5 Pharmicell Co., Ltd. Recent Development

11.15 Regrow Biosciences Pvt Ltd.

11.15.1 Regrow Biosciences Pvt Ltd. Company Details

11.15.2 Regrow Biosciences Pvt Ltd. Business Overview

11.15.3 Regrow Biosciences Pvt Ltd. Autologous Stem Cell & Non-stem Cell Therapies Introduction

11.15.4 Regrow Biosciences Pvt Ltd. Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

11.15.5 Regrow Biosciences Pvt Ltd. Recent Development

11.16 Tegoscience

11.16.1 Tegoscience Company Details

11.16.2 Tegoscience Business Overview

11.16.3 Tegoscience Autologous Stem Cell & Non-stem Cell Therapies Introduction

11.16.4 Tegoscience Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

11.16.5 Tegoscience Recent Development

11.17 Vericel Corporation

11.17.1 Vericel Corporation Company Details

11.17.2 Vericel Corporation Business Overview

11.17.3 Vericel Corporation Autologous Stem Cell & Non-stem Cell Therapies Introduction

11.17.4 Vericel Corporation Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

11.17.5 Vericel Corporation Recent Development

11.18 W (Cayman) Therapeutics Co. Ltd.

11.18.1 W (Cayman) Therapeutics Co. Ltd. Company Details

11.18.2 W (Cayman) Therapeutics Co. Ltd. Business Overview

11.18.3 W (Cayman) Therapeutics Co. Ltd. Autologous Stem Cell & Non-stem Cell Therapies Introduction

11.18.4 W (Cayman) Therapeutics Co. Ltd. Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

11.18.5 W (Cayman) Therapeutics Co. Ltd. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

ANTEROGEN CO LTD

Apac Biotech

Bristol Myers Squibb Company

Johnson & Johnson

Novartis

PHARMICELL

Regrow Biosciences Pvt Ltd

Vericel Corporation

CARsgen Therapeutics Holdings Limited

Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.)

Green Cross Holdings Co., Ltd. (GC Cell)

Healiva SA

ImmunoACT

Iaso Biotherapeutics

Lovance Biotherapeutics, Inc.

Tegoscience

W (Cayman) Therapeutics Co. Ltd.

List of Tables

Table 1. Global Autologous Stem Cell & Non-stem Cell Therapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of CAR-T

Table 3. Key Players of Tumor Infiltrating Lymphocyte

Table 4. Global Autologous Stem Cell & Non-stem Cell Therapies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Autologous Stem Cell & Non-stem Cell Therapies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Autologous Stem Cell & Non-stem Cell Therapies Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Autologous Stem Cell & Non-stem Cell Therapies Market Share by Region (2020-2025)

Table 8. Global Autologous Stem Cell & Non-stem Cell Therapies Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Autologous Stem Cell & Non-stem Cell Therapies Market Share by Region (2026-2031)

Table 10. Autologous Stem Cell & Non-stem Cell Therapies Market Trends

Table 11. Autologous Stem Cell & Non-stem Cell Therapies Market Drivers

Table 12. Autologous Stem Cell & Non-stem Cell Therapies Market Challenges

Table 13. Autologous Stem Cell & Non-stem Cell Therapies Market Restraints

Table 14. Global Autologous Stem Cell & Non-stem Cell Therapies Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Autologous Stem Cell & Non-stem Cell Therapies Market Share by Players (2020-2025)

Table 16. Global Top Autologous Stem Cell & Non-stem Cell Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous Stem Cell & Non-stem Cell Therapies as of 2024)

Table 17. Ranking of Global Top Autologous Stem Cell & Non-stem Cell Therapies Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Autologous Stem Cell & Non-stem Cell Therapies Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Autologous Stem Cell & Non-stem Cell Therapies, Headquarters and Area Served

Table 20. Global Key Players of Autologous Stem Cell & Non-stem Cell Therapies, Product and Application

Table 21. Global Key Players of Autologous Stem Cell & Non-stem Cell Therapies, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Autologous Stem Cell & Non-stem Cell Therapies Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Autologous Stem Cell & Non-stem Cell Therapies Revenue Market Share by Type (2020-2025)

Table 25. Global Autologous Stem Cell & Non-stem Cell Therapies Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Autologous Stem Cell & Non-stem Cell Therapies Revenue Market Share by Type (2026-2031)

Table 27. Global Autologous Stem Cell & Non-stem Cell Therapies Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Autologous Stem Cell & Non-stem Cell Therapies Revenue Market Share by Application (2020-2025)

Table 29. Global Autologous Stem Cell & Non-stem Cell Therapies Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Autologous Stem Cell & Non-stem Cell Therapies Revenue Market Share by Application (2026-2031)

Table 31. North America Autologous Stem Cell & Non-stem Cell Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Autologous Stem Cell & Non-stem Cell Therapies Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Autologous Stem Cell & Non-stem Cell Therapies Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Autologous Stem Cell & Non-stem Cell Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Autologous Stem Cell & Non-stem Cell Therapies Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Autologous Stem Cell & Non-stem Cell Therapies Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Autologous Stem Cell & Non-stem Cell Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Autologous Stem Cell & Non-stem Cell Therapies Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Autologous Stem Cell & Non-stem Cell Therapies Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Market Size by Country (2026-2031) & (US$ Million)

Table 46. Anterogen Co., Ltd. Company Details

Table 47. Anterogen Co., Ltd. Business Overview

Table 48. Anterogen Co., Ltd. Autologous Stem Cell & Non-stem Cell Therapies Product

Table 49. Anterogen Co., Ltd. Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025) & (US$ Million)

Table 50. Anterogen Co., Ltd. Recent Development

Table 51. APAC Biotech Company Details

Table 52. APAC Biotech Business Overview

Table 53. APAC Biotech Autologous Stem Cell & Non-stem Cell Therapies Product

Table 54. APAC Biotech Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025) & (US$ Million)

Table 55. APAC Biotech Recent Development

Table 56. Bristol-Myers Squibb Company Company Details

Table 57. Bristol-Myers Squibb Company Business Overview

Table 58. Bristol-Myers Squibb Company Autologous Stem Cell & Non-stem Cell Therapies Product

Table 59. Bristol-Myers Squibb Company Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025) & (US$ Million)

Table 60. Bristol-Myers Squibb Company Recent Development

Table 61. CARsgen Therapeutics Holdings Limited Company Details

Table 62. CARsgen Therapeutics Holdings Limited Business Overview

Table 63. CARsgen Therapeutics Holdings Limited Autologous Stem Cell & Non-stem Cell Therapies Product

Table 64. CARsgen Therapeutics Holdings Limited Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025) & (US$ Million)

Table 65. CARsgen Therapeutics Holdings Limited Recent Development

Table 66. Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.) Company Details

Table 67. Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.) Business Overview

Table 68. Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.) Autologous Stem Cell & Non-stem Cell Therapies Product

Table 69. Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.) Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025) & (US$ Million)

Table 70. Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.) Recent Development

Table 71. Gilead Sciences, Inc. Company Details

Table 72. Gilead Sciences, Inc. Business Overview

Table 73. Gilead Sciences, Inc. Autologous Stem Cell & Non-stem Cell Therapies Product

Table 74. Gilead Sciences, Inc. Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025) & (US$ Million)

Table 75. Gilead Sciences, Inc. Recent Development

Table 76. Green Cross Holdings Co., Ltd. (GC Cell) Company Details

Table 77. Green Cross Holdings Co., Ltd. (GC Cell) Business Overview

Table 78. Green Cross Holdings Co., Ltd. (GC Cell) Autologous Stem Cell & Non-stem Cell Therapies Product

Table 79. Green Cross Holdings Co., Ltd. (GC Cell) Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025) & (US$ Million)

Table 80. Green Cross Holdings Co., Ltd. (GC Cell) Recent Development

Table 81. Healiva SA Company Details

Table 82. Healiva SA Business Overview

Table 83. Healiva SA Autologous Stem Cell & Non-stem Cell Therapies Product

Table 84. Healiva SA Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025) & (US$ Million)

Table 85. Healiva SA Recent Development

Table 86. ImmunoACT Company Details

Table 87. ImmunoACT Business Overview

Table 88. ImmunoACT Autologous Stem Cell & Non-stem Cell Therapies Product

Table 89. ImmunoACT Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025) & (US$ Million)

Table 90. ImmunoACT Recent Development

Table 91. Iaso Biotherapeutics Company Details

Table 92. Iaso Biotherapeutics Business Overview

Table 93. Iaso Biotherapeutics Autologous Stem Cell & Non-stem Cell Therapies Product

Table 94. Iaso Biotherapeutics Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025) & (US$ Million)

Table 95. Iaso Biotherapeutics Recent Development

Table 96. Johnson & Johnson Company Details

Table 97. Johnson & Johnson Business Overview

Table 98. Johnson & Johnson Autologous Stem Cell & Non-stem Cell Therapies Product

Table 99. Johnson & Johnson Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025) & (US$ Million)

Table 100. Johnson & Johnson Recent Development

Table 101. Lovance Biotherapeutics, Inc. Company Details

Table 102. Lovance Biotherapeutics, Inc. Business Overview

Table 103. Lovance Biotherapeutics, Inc. Autologous Stem Cell & Non-stem Cell Therapies Product

Table 104. Lovance Biotherapeutics, Inc. Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025) & (US$ Million)

Table 105. Lovance Biotherapeutics, Inc. Recent Development

Table 106. Novartis AG Company Details

Table 107. Novartis AG Business Overview

Table 108. Novartis AG Autologous Stem Cell & Non-stem Cell Therapies Product

Table 109. Novartis AG Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025) & (US$ Million)

Table 110. Novartis AG Recent Development

Table 111. Pharmicell Co., Ltd. Company Details

Table 112. Pharmicell Co., Ltd. Business Overview

Table 113. Pharmicell Co., Ltd. Autologous Stem Cell & Non-stem Cell Therapies Product

Table 114. Pharmicell Co., Ltd. Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025) & (US$ Million)

Table 115. Pharmicell Co., Ltd. Recent Development

Table 116. Regrow Biosciences Pvt Ltd. Company Details

Table 117. Regrow Biosciences Pvt Ltd. Business Overview

Table 118. Regrow Biosciences Pvt Ltd. Autologous Stem Cell & Non-stem Cell Therapies Product

Table 119. Regrow Biosciences Pvt Ltd. Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025) & (US$ Million)

Table 120. Regrow Biosciences Pvt Ltd. Recent Development

Table 121. Tegoscience Company Details

Table 122. Tegoscience Business Overview

Table 123. Tegoscience Autologous Stem Cell & Non-stem Cell Therapies Product

Table 124. Tegoscience Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025) & (US$ Million)

Table 125. Tegoscience Recent Development

Table 126. Vericel Corporation Company Details

Table 127. Vericel Corporation Business Overview

Table 128. Vericel Corporation Autologous Stem Cell & Non-stem Cell Therapies Product

Table 129. Vericel Corporation Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025) & (US$ Million)

Table 130. Vericel Corporation Recent Development

Table 131. W (Cayman) Therapeutics Co. Ltd. Company Details

Table 132. W (Cayman) Therapeutics Co. Ltd. Business Overview

Table 133. W (Cayman) Therapeutics Co. Ltd. Autologous Stem Cell & Non-stem Cell Therapies Product

Table 134. W (Cayman) Therapeutics Co. Ltd. Revenue in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025) & (US$ Million)

Table 135. W (Cayman) Therapeutics Co. Ltd. Recent Development

Table 136. Research Programs/Design for This Report

Table 137. Key Data Information from Secondary Sources

Table 138. Key Data Information from Primary Sources

Table 139. Authors List of This Report

List of Figures

Figure 1. Autologous Stem Cell & Non-stem Cell Therapies Picture

Figure 2. Global Autologous Stem Cell & Non-stem Cell Therapies Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Autologous Stem Cell & Non-stem Cell Therapies Market Share by Type: 2024 VS 2031

Figure 4. CAR-T Features

Figure 5. Tumor Infiltrating Lymphocyte Features

Figure 6. Global Autologous Stem Cell & Non-stem Cell Therapies Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Autologous Stem Cell & Non-stem Cell Therapies Market Share by Application: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Surgery Center Case Studies

Figure 10. Other Case Studies

Figure 11. Autologous Stem Cell & Non-stem Cell Therapies Report Years Considered

Figure 12. Global Autologous Stem Cell & Non-stem Cell Therapies Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Autologous Stem Cell & Non-stem Cell Therapies Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Autologous Stem Cell & Non-stem Cell Therapies Market Share by Region: 2024 VS 2031

Figure 15. Global Autologous Stem Cell & Non-stem Cell Therapies Market Share by Players in 2024

Figure 16. Global Top Autologous Stem Cell & Non-stem Cell Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous Stem Cell & Non-stem Cell Therapies as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Autologous Stem Cell & Non-stem Cell Therapies Revenue in 2024

Figure 18. North America Autologous Stem Cell & Non-stem Cell Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Autologous Stem Cell & Non-stem Cell Therapies Market Share by Country (2020-2031)

Figure 20. United States Autologous Stem Cell & Non-stem Cell Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Autologous Stem Cell & Non-stem Cell Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Autologous Stem Cell & Non-stem Cell Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Autologous Stem Cell & Non-stem Cell Therapies Market Share by Country (2020-2031)

Figure 24. Germany Autologous Stem Cell & Non-stem Cell Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Autologous Stem Cell & Non-stem Cell Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Autologous Stem Cell & Non-stem Cell Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Autologous Stem Cell & Non-stem Cell Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Autologous Stem Cell & Non-stem Cell Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Autologous Stem Cell & Non-stem Cell Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Autologous Stem Cell & Non-stem Cell Therapies Market Share by Region (2020-2031)

Figure 32. China Autologous Stem Cell & Non-stem Cell Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Autologous Stem Cell & Non-stem Cell Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Autologous Stem Cell & Non-stem Cell Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Autologous Stem Cell & Non-stem Cell Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Autologous Stem Cell & Non-stem Cell Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Autologous Stem Cell & Non-stem Cell Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Autologous Stem Cell & Non-stem Cell Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Autologous Stem Cell & Non-stem Cell Therapies Market Share by Country (2020-2031)

Figure 40. Mexico Autologous Stem Cell & Non-stem Cell Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Autologous Stem Cell & Non-stem Cell Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Autologous Stem Cell & Non-stem Cell Therapies Market Share by Country (2020-2031)

Figure 44. Turkey Autologous Stem Cell & Non-stem Cell Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Autologous Stem Cell & Non-stem Cell Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Autologous Stem Cell & Non-stem Cell Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Anterogen Co., Ltd. Revenue Growth Rate in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

Figure 48. APAC Biotech Revenue Growth Rate in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

Figure 49. Bristol-Myers Squibb Company Revenue Growth Rate in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

Figure 50. CARsgen Therapeutics Holdings Limited Revenue Growth Rate in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

Figure 51. Dendreon Pharmaceuticals LLC (Sanpower Group Co., Ltd.) Revenue Growth Rate in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

Figure 52. Gilead Sciences, Inc. Revenue Growth Rate in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

Figure 53. Green Cross Holdings Co., Ltd. (GC Cell) Revenue Growth Rate in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

Figure 54. Healiva SA Revenue Growth Rate in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

Figure 55. ImmunoACT Revenue Growth Rate in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

Figure 56. Iaso Biotherapeutics Revenue Growth Rate in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

Figure 57. Johnson & Johnson Revenue Growth Rate in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

Figure 58. Lovance Biotherapeutics, Inc. Revenue Growth Rate in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

Figure 59. Novartis AG Revenue Growth Rate in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

Figure 60. Pharmicell Co., Ltd. Revenue Growth Rate in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

Figure 61. Regrow Biosciences Pvt Ltd. Revenue Growth Rate in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

Figure 62. Tegoscience Revenue Growth Rate in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

Figure 63. Vericel Corporation Revenue Growth Rate in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

Figure 64. W (Cayman) Therapeutics Co. Ltd. Revenue Growth Rate in Autologous Stem Cell & Non-stem Cell Therapies Business (2020-2025)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions